Extract notice to the Minister

Vistitan

Common name / Subject : bimatoprost
Name of the manufacturer : Sandoz
Form : Sol. oph.
Dosage : 0,03%

Indication : Traitement du glaucome ou de l'hypertension oculaire

INESSS' Recommendation
Sous étude

Minister's decisions
Maintenir sous étude

Evaluation published on February 01, 2017

Subscribe to our newsletter now

Subscription